BIVRX vs. JAKVX
BIVRX (Invenomic Fund) and JAKVX (John Hancock Disciplined Value Global Long/Short Fund Class R6) are both Long-Short funds. Over the past year, BIVRX returned -10.04% vs 26.35% for JAKVX. At a correlation of -0.18, they often move in opposite directions. BIVRX charges 2.48%/yr vs 1.54%/yr for JAKVX.
Performance
BIVRX vs. JAKVX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BIVRX achieves a -15.45% return, which is significantly lower than JAKVX's 12.93% return.
BIVRX
- 1D
- -2.33%
- 1M
- -8.20%
- YTD
- -15.45%
- 6M
- -10.79%
- 1Y
- -10.04%
- 3Y*
- -5.34%
- 5Y*
- 5.72%
- 10Y*
- —
JAKVX
- 1D
- -0.49%
- 1M
- 1.00%
- YTD
- 12.93%
- 6M
- 13.88%
- 1Y
- 26.35%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
BIVRX vs. JAKVX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
BIVRX Invenomic Fund | -15.45% | 5.95% |
JAKVX John Hancock Disciplined Value Global Long/Short Fund Class R6 | 12.93% | 17.29% |
Correlation
The correlation between BIVRX and JAKVX is -0.18, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.18 |
Correlation (All Time) Calculated using the full available price history since Apr 29, 2025 | -0.18 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIVRX vs. JAKVX — Risk / Return Rank
BIVRX
JAKVX
BIVRX vs. JAKVX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invenomic Fund (BIVRX) and John Hancock Disciplined Value Global Long/Short Fund Class R6 (JAKVX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BIVRX | JAKVX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -4.01 | ||
| Sortino ratioReturn per unit of downside risk | -5.58 | ||
| Omega ratioGain probability vs. loss probability | 0.95 | 1.72 | -0.77 |
| Calmar ratioReturn relative to maximum drawdown | -0.47 | 5.22 | -5.70 |
| Martin ratioReturn relative to average drawdown | -1.23 | 18.35 | -19.58 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BIVRX | JAKVX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.40 | 3.61 | -4.01 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.33 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.70 | 4.00 | -3.30 |
Drawdowns
BIVRX vs. JAKVX - Drawdown Comparison
The maximum BIVRX drawdown since its inception was -21.14%, which is greater than JAKVX's maximum drawdown of -5.16%. Use the drawdown chart below to compare losses from any high point for BIVRX and JAKVX.
Loading charts...
Drawdown Indicators
| BIVRX | JAKVX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -21.14% | -5.16% | -15.98% |
Max Drawdown (1Y)Largest decline over 1 year | -20.70% | -5.16% | -15.54% |
Max Drawdown (3Y)Largest decline over 3 years | -21.14% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -21.14% | — | — |
Current DrawdownCurrent decline from peak | -21.14% | -0.71% | -20.43% |
Average DrawdownAverage peak-to-trough decline | -6.06% | -0.80% | -5.26% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.93% | 1.47% | +6.46% |
Volatility
BIVRX vs. JAKVX - Volatility Comparison
Invenomic Fund (BIVRX) has a higher volatility of 12.21% compared to John Hancock Disciplined Value Global Long/Short Fund Class R6 (JAKVX) at 2.50%. This indicates that BIVRX's price experiences larger fluctuations and is considered to be riskier than JAKVX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIVRX | JAKVX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.21% | 2.50% | +9.71% |
Volatility (6M)Calculated over the trailing 6-month period | 20.24% | 5.91% | +14.33% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.31% | 7.48% | +16.83% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.55% | 7.33% | +10.22% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.57% | 7.33% | +10.24% |
BIVRX vs. JAKVX - Expense Ratio Comparison
BIVRX has a 2.48% expense ratio, which is higher than JAKVX's 1.54% expense ratio.
Dividends
BIVRX vs. JAKVX - Dividend Comparison
BIVRX's dividend yield for the trailing twelve months is around 2.28%, less than JAKVX's 7.50% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
BIVRX Invenomic Fund | 2.28% | 1.93% | 3.55% | 20.26% | 28.43% | 3.00% | 3.11% | 3.21% | 4.82% | 1.21% |
JAKVX John Hancock Disciplined Value Global Long/Short Fund Class R6 | 7.50% | 8.47% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BIVRX and JAKVX have a correlation of -0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BIVRX has higher volatility (12.21%) compared to JAKVX (2.50%). In terms of maximum drawdown, BIVRX dropped -21.14% vs JAKVX's -5.16%.
JAKVX currently has the higher Sharpe Ratio (3.61 vs -0.40), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BIVRX and JAKVX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer